Alphabet's drug AI company Isomorphic Labs completes $500 million C round financing
Isomorphic Labs completes a total of $500 million in C round financing, led by Greenoaks and Sequoia Capital, with Alphabet continuing its investment; the company will use the funds to advance the development of fundamental simulation models, expand the scale of drug candidate projects, and build a global AI-driven biological engineering infrastructure.
Same story2 other outlets also reported this
- ITHome · AI··First·Reading now
Alphabet's drug AI company Isomorphic Labs completes $500 million C round financing
- TechCrunch · AI··+1 h 11 min
Isomorphic Labs raises $5 billion, aiming to advance AI drug candidates into clinical trials
Adds:TechCrunch mentions the company is based on DeepMind's AlphaFold model and has achieved 'positive preclinical results' in oncology and immunology.
In order of publication · later reports are added as they appear · Compared by AI from each outlet’s title and summary
Source: ITHome · AI · ithome.com